Bladder Cancer, An Issue of Hematology/Oncology Clinics of North America, 1st Edition
Author :
Joaquim Bellmunt
This issue of Hematology/Oncology Clinics of North America, guest edited by Dr. Joaquin Bellmunt, is devoted to Bladder Cancer. Articles in this issue include: Diagnosis and Staging of Bladder Cancer; Epidemiology of Bladder Cancer; Molecular Biology
...view more
This issue of Hematology/Oncology Clinics of North America, guest edited by Dr. Joaquin Bellmunt, is devoted to Bladder Cancer. Articles in this issue include: Diagnosis and Staging of Bladder Cancer; Epidemiology of Bladder Cancer; Molecular Biology of Bladder Cancer; Pharmacogenomics in Bladder Cancer; Management of Non-muscle Invasive Bladder Cancer; Non-urothelial Bladder Cancer and Rare Variant Histologies; Management of UUT; New Trends in Surgical Management of Bladder Cancer; Bladder Preservation Strategies; Perioperative Therapy of Bladder Cancer (Neoadjuvant and Adjuvant); First Line Treatment and Prognostic Factors of Metastatic Disease: Platinum Eligible Patients; First Line Treatment of Metastatic Disease: Platinum Ineligible Patients; Salvage Therapy in Metastatic Disease; and Future Directions and Targeted Therapies in Bladder Cancer.
Your discount code here : #FB456
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYS
This issue of Hematology/Oncology Clinics of North America, guest edited by Dr. Joaquin Bellmunt, is devoted to Bladder Cancer. Articles in this issue include: Diagnosis and Staging of Bladder Cancer; Epidemiology of Bladder Cancer; Molecular Biology of Bladder Cancer; Pharmacogenomics in Bladder Cancer; Management of Non-muscle Invasive Bladder Cancer; Non-urothelial Bladder Cancer and Rare Variant Histologies; Management of UUT; New Trends in Surgical Management of Bladder Cancer; Bladder Preservation Strategies; Perioperative Therapy of Bladder Cancer (Neoadjuvant and Adjuvant); First Line Treatment and Prognostic Factors of Metastatic Disease: Platinum Eligible Patients; First Line Treatment of Metastatic Disease: Platinum Ineligible Patients; Salvage Therapy in Metastatic Disease; and Future Directions and Targeted Therapies in Bladder Cancer.
Author Information
By Joaquim Bellmunt, MD, PhD, Director, Bladder Cancer Center
Dana-Farber Cancer Institute
Dana-Farber/Brigham and Women's Cancer Center
Associate Professor, Harvard Medical School
ISBN Number | 9780323359764 |
---|---|
Main Author | By Joaquim Bellmunt, MD, PhD |
Copyright Year | 2015 |
Edition Number | 1 |
Format | Book |
Trim | 152w x 229h |
Imprint | Elsevier |
Page Count | 0 |
Publication Date | 12 Apr 2015 |
Stock Status | IN STOCK - This may take up to 5 business days to ship |
Write Your Own Review
Only registered users can write reviews. Please sign in or create an account
product
https://www.us.elsevierhealth.com/bladder-cancer-an-issue-of-hematologyoncology-clinics-of-north-america-9780323359764.html
1630
Bladder Cancer, An Issue of Hematology/Oncology Clinics of North America
https://www.us.elsevierhealth.com/media/catalog/product/9/7/9780323359764.jpg
79.19
98.99
USD
InStock
/Medicine/Hematology
/Clinics
/Clinics
137
4388725
5255041
This issue of Hematology/Oncology Clinics of North America, guest edited by Dr. Joaquin Bellmunt, is devoted to Bladder Cancer. Articles in this issue include: Diagnosis and Staging of Bladder Cancer; Epidemiology of Bladder Cancer; Molecular Biology of Bladder Cancer; Pharmacogenomics in Bladder Cancer; Management of Non-muscle Invasive Bladder Cancer; Non-urothelial Bladder Cancer and Rare Variant Histologies; Management of UUT; New Trends in Surgical Management of Bladder Cancer; Bladder Preservation Strategies; Perioperative Therapy of Bladder Cancer (Neoadjuvant and Adjuvant); First Line Treatment and Prognostic Factors of Metastatic Disease: Platinum Eligible Patients; First Line Treatment of Metastatic Disease: Platinum Ineligible Patients; Salvage Therapy in Metastatic Disease; and Future Directions and Targeted Therapies in Bladder Cancer. This issue of Hematology/Oncology Clinics of North America, guest edited by Dr. Joaquin Bellmunt, is devoted to Bladder Cancer. Articles in this issue include: Diagnosis and Staging of Bladder Cancer; Epidemiology of Bladder Cancer; Molecular Biology of Bladder Cancer; Pharmacogenomics in Bladder Cancer; Management of Non-muscle Invasive Bladder Cancer; Non-urothelial Bladder Cancer and Rare Variant Histologies; Management of UUT; New Trends in Surgical Management of Bladder Cancer; Bladder Preservation Strategies; Perioperative Therapy of Bladder Cancer (Neoadjuvant and Adjuvant); First Line Treatment and Prognostic Factors of Metastatic Disease: Platinum Eligible Patients; First Line Treatment of Metastatic Disease: Platinum Ineligible Patients; Salvage Therapy in Metastatic Disease; and Future Directions and Targeted Therapies in Bladder Cancer.
0
0
add-to-cart
9780323359764
2015
Professional
By Joaquim Bellmunt, MD, PhD
2015
1
Book
152w x 229h
Elsevier
0
Apr 12, 2015
IN STOCK - This may take up to 5 business days to ship
By <STRONG>Joaquim Bellmunt</STRONG>, MD, PhD, Director, Bladder Cancer Center
Dana-Farber Cancer Institute
Dana-Farber/Brigham and Women's Cancer Center
Associate Professor, Harvard Medical School
Clinics
Clinics
The Clinics: Internal Medicine
No
No
No
No
Please Select
Please Select
Please Select
Related Products
-
25% OFF Book
-
25% OFF Book
-
25% OFF Flash Cards
-
30% OFF Flash Cards
-
25% OFF BookGray's Clinical Photographic Dissector of the Human Body
Marios Loukas
Oct 2018
Special Price $56.24 $74.99 -
25% OFF Book
-
20% OFF Book
-
20% OFF Online ResourceNetter's Dissection Video Modules (Retail Access Card)
and Frank H. Netter
Oct 2015
Special Price $144.79 $180.99 -
25% OFF Book
-
30% OFF Flash Cards